SCHEMBL21414453

SCHEMBL21414453

CCC(C)c1ccc(CN2CCC(C#N)CC2)cn1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHEK1 O14757 1/20 0.41
▸ ACHE P22303 1/20 0.41
▸ LTA4H P09960 3/20 0.41
▸ KMT2A Q03164 4/20 0.38
▸ HRH3 Q9Y5N1 3/20 0.36
▸ JAK1 P23458 1/20 0.35
▸ JAK2 O60674 1/20 0.35
▸ PRKAA2 P54646 1/20 0.35
▸ MEN1 O00255 3/20 0.34
▸ ALDH1A1 P00352 2/20 0.34
▸ CYP2D6 P10635 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ CCNK O75909 1/20 0.33
▸ CDK12 Q9NYV4 1/20 0.33
▸ TP53 P04637 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ ALOX12 P18054 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ ATM Q13315 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20203525 0.89 ACHE (0.43) CHEK1ACHELTA4HKMT2AHRH3
SCHEMBL21414381 0.81 HRH3 (0.47) ACHELTA4HKMT2AHRH3MEN1
SCHEMBL21414345 0.81 KMT2A (0.41) KMT2AHRH3MEN1ALDH1A1CYP2D6
SCHEMBL21414378 0.80 ALDH1A1 (0.49) KMT2AMEN1ALDH1A1RAB9ATP53
SCHEMBL21414385 0.79 LMNA (0.46) KMT2AHRH3MEN1ALDH1A1RAB9A
SCHEMBL21414369 0.78 CXCR4 (0.44) KMT2AHRH3MEN1
SCHEMBL22650374 0.77 ACHE (0.45) CHEK1ACHELTA4HKMT2AHRH3
SCHEMBL21414349 0.76 ALDH1A1 (0.50) KMT2AHRH3MEN1ALDH1A1RAB9A
SCHEMBL31612484 0.71 ALDH1A1 (0.54) ACHELTA4HKMT2AHRH3MEN1
SCHEMBL20203580 0.71 ALDH1A1 (0.50) ACHELTA4HKMT2AHRH3MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3546458-B1 ((PYRIDIN-2-YL)-AMINO)PYRIDO[3,4-D]PYRIMIDINE AND ((PYRIDAZIN-3-YL)-AMINO)PYRIDO[3,4-D]PYRIMIDINE DERIVATIVES AS CDK4/6 INHIBITORS FOR TREATING E.G. RHEUMATOID ARTHRITIS, ARTERIOSCLEROSIS, PULMONARY FIBROSIS, CEREBRAL INFARCTION OR CANCER TEIJIN PHARMA LTD (JP) 2021-01-06 — — EP disclosed
EP-3546458-A1 PYRIDO[3, 4-D]PYRIMIDINE DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF Teijin Pharma Limited (JP) 2019-10-02 — — EP disclosed
Send feedback